GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Net Margin %

Abaxis (Abaxis) Net Margin % : 14.75% (As of Mar. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Abaxis's Net Income for the three months ended in Mar. 2018 was $10.0 Mil. Abaxis's Revenue for the three months ended in Mar. 2018 was $67.9 Mil. Therefore, Abaxis's net margin for the quarter that ended in Mar. 2018 was 14.75%.

The historical rank and industry rank for Abaxis's Net Margin % or its related term are showing as below:


ABAX's Net Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -11.145
* Ranked among companies with meaningful Net Margin % only.

Abaxis Net Margin % Historical Data

The historical data trend for Abaxis's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Net Margin % Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.75 13.49 14.45 14.40 11.11

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.97 10.87 11.22 7.08 14.75

Competitive Comparison of Abaxis's Net Margin %

For the Diagnostics & Research subindustry, Abaxis's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Net Margin % distribution charts can be found below:

* The bar in red indicates where Abaxis's Net Margin % falls into.



Abaxis Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Abaxis's Net Margin for the fiscal year that ended in Mar. 2018 is calculated as

Net Margin=Net Income (A: Mar. 2018 )/Revenue (A: Mar. 2018 )
=27.177/244.7
=11.11 %

Abaxis's Net Margin for the quarter that ended in Mar. 2018 is calculated as

Net Margin=Net Income (Q: Mar. 2018 )/Revenue (Q: Mar. 2018 )
=10.02/67.918
=14.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abaxis  (NAS:ABAX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Abaxis Net Margin % Related Terms

Thank you for viewing the detailed overview of Abaxis's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020